Alyeska Investment Group
CTIC

Alyeska Investment Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Alyeska Investment Group’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
2018
Q1 		$767K Buy
2017
Q3 		– Sell
2017
Q2 		$1.54M Buy
2016
Q3 		– Sell
2016
Q2 		$268K Buy
2016
Q1 		$411K Buy
2015
Q4 		$923K Buy